St. Jude Looks Beyond ICDs To Emerging AF Market For Growth In 2006
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical expects its atrial fibrillation division to be a consistent revenue driver after ICDs due to its broad range of products and growing market opportunity
You may also be interested in...
AF Ablation Lacks Evidence, Despite Growing Adoption – TEC Assessment
A recent BlueCross BlueShield Association assessment of atrial fibrillation ablation echoes widespread belief among payors and doctors that the technique is still evolving
AF Ablation Lacks Evidence, Despite Growing Adoption – TEC Assessment
A recent BlueCross BlueShield Association assessment of atrial fibrillation ablation echoes widespread belief among payors and doctors that the technique is still evolving
Top Electrophysiologists Assess AF Balloon Ablation Devices
Atrial fibrillation balloon ablation devices could benefit from a fundamental design change, proposed leading AF ablation electrophysiologists at the Boston AF Symposium Jan. 14